NMR in Crystals and Powders of Topazes with Different Colours

The present work is a part of the large project with purpose to investigate microstructure and electronic structure of natural topazes using NMR method. To reach this task we determined the relative contents of fluorine and hydrogen in crystals blue, colorless, wine and wine irradiated topazes. Then we determined the electric field gradients in site of aluminium atoms by NMR method, calculated EFG using ab initio method, and measured relaxation time dependence on heating temperature for blue, colorless, Swiss blue and sky blue topazes. Nuclear magnetic resonance (NMR) is an effective method to investigate the local structure in the crystal. The NMR study of the single crystal gives detailed information especially about the local crystal structure. As a result of this work we have received practical data, which is possible to use in future for making personal dosimetry and for preparation of mullite, which is widely used in traditional and advanced ceramic materials.

Early Detection of Alzheimer's Disease Beta-amyloid Pathology -Applicability of Positron Emission Tomography with the Amyloid Radioligand 11C-PIB

Early Detection of Alzheimer's Disease Beta-amyloid Pathology -Applicability of Positron Emission Tomography with the Amyloid Radioligand ¹¹C-PIB Accumulation of beta amyloid (Abeta) in the brain is characteristic for Alzheimer’s disease (AD). Carbon-11 labeled 2-(4’-methylaminophenyl)-6-hydroxybenzothiazole (¹¹C-PIB) is a novel positron emission tomography (PET) amyloid imaging agent that appears to be applicable for in vivo Abeta plaque detection and quantitation. The biodistribution and radiation dosimetry of ¹¹C-PIB were investigated in 16 healthy subjects. The reproducibility of a simplified ¹¹C-PIB quantitation method was evaluated with a test-retest study on 6 AD patients and 4 healthy control subjects. Brain ¹¹C-PIB uptake and its possible association with brain atrophy rates were studied over a two-year follow-up in 14 AD patients and 13 healthy controls. Nine monozygotic and 8 dizygotic twin pairs discordant for cognitive impairment and 9 unrelated controls were examined to determine whether brain Abeta accumulation could be detected with ¹¹C-PIB PET in cognitively intact persons who are at increased genetic risk for AD. The highest absorbed radiation dose was received by the gallbladder wall (41.5 mjuGy/MBq). About 20 % of the injected radioactivity was excreted into urine, and the effective whole-body radiation dose was 4.7 mjuSv/MBq. Such a dose allows repeated scans of individual subjects. The reproducibility of the simplified ¹¹C-PIB quantitation was good or excellent both at the regional level (VAR 0.9-5.5 %) and at the voxel level (VAR 4.2-6.4 %). ¹¹C-PIB uptake did not increase during 24 months’ follow-up of subjects with mild or moderate AD, even though brain atrophy and cognitive decline progressed. Baseline neocortical ¹¹C-PIB uptake predicted subsequent volumetric brain changes in healthy control subjects (r = 0.725, p = 0.005). Cognitively intact monozygotic co-twins – but not dizygotic co-twins – of memory-impaired subjects exhibited increased ¹¹C-PIB uptake (117-121 % of control mean) in their temporal and parietal cortices and the posterior cingulate (p<0.05), when compared with unrelated controls. This increased uptake may be representative of an early AD process, and genetic factors seem to play an important role in the development of AD-like Abeta plaque pathology. ¹¹C-PIB PET may be a useful method for patient selection and follow-up for early-phase intervention trials of novel therapeutic agents. AD might be detectable in high-risk individuals in its presymptomatic stage with ¹¹C-PIB PET, which would have important consequences both for future diagnostics and for research on disease-modifying treatments.

Käsien ekvivalenttiannosten määritys ja osakehoannosten dosimetria Loviisan voimalaitoksella

Loviisan voimalaitoksen valvonta-alueen työt luokitellaan viranomaisohjeistuksen ja lainsäädännön mukaiseksi säteilytyöksi. Toiminnan harjoittajalla on velvollisuus seurata säteilytyötä tekevien työntekijöiden säteilyaltistusta ja Loviisan voimalaitoksella seurataan kaikkien valvonta-alueen työntekijöiden efektiivistä säteilyannosta. Tämän lisäksi viranomaisohjeistus velvoittaa seuraamaan erikseen kehon osien ekvivalenttiannosta, jos säteilyaltistus on epätasaista. Loviisan voimalaitoksella on käsien säteilyaltistuksen kannalta kriittisiksi määritellyissä työryhmissä mitattu työntekijöiden käsien ekvivalenttiannosta lisäannosmittareilla. Tässä kandidaatintyössä tehdään katsaus Loviisan voimalaitoksella suoritetusta käsien ekvivalenttiannoksen tarkkailusta vuosilta 2007 - 2015 ja osakehoannosten dosimetriakäytännöistä. Tulosten perusteella annetaan suositukset sille, millaisissa työtehtävissä ja millä työryhmillä tulisi jatkossa määrittää kehon osien ja erityisesti käsien ekvivalenttiannosta erikseen. Johtopäätöksenä annetaan suositukset myös tarkkailujakson pituudesta ja esitetään tulosten parempaan kattavuuteen tähtääviä operatiivisia suosituksia.